Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.

Add item related to this paper

  • MiniManuscript ID
    62671
  • Pubmed ID
    9415404